Coulter Partners secures Senior Vice President of Partnerships for Entia

Working at the frontiers of remote patient monitoring and predictive analytics, Entia has combined novel at-home blood testing technology and digital solutions to deliver personalized insights into cancer patients’ journeys through treatment. The company’s flagship innovation – Liberty – is the world’s first at-home blood monitoring solution for people undergoing cancer treatment. The analyzer which helps cancer centers deliver more proactive care from within the home has been given UK regulatory approval earlier this year.

With extensive experience in forging strategic alliances, Timothy Broke-Smith will focus on establishing scalable partnerships with key life science innovators and healthcare service partners. His deep understanding of the healthcare industry, coupled with his passion for innovation, will be instrumental in accelerating Entia's mission to revolutionize cancer care.

“We are thrilled to welcome Tim to the Entia team,” said Dr. Toby Basey-Fisher, CEO and Founder of Entia. "Through our world-leading remote blood monitoring solutions, we aim to enhance patient care and improve treatment tolerability, enabling patients to spend more time doing what they love. Tim’s dedication to making a difference for patients will help us build a network of partnerships that deliver real value to people living with cancer, healthcare professionals, and healthcare systems.”

Dr. Basey-Fisher continued: "We are incredibly grateful to Coulter Partners for their exceptional work in identifying and placing such a talented individual as Tim. The pool of candidates with the unique blend of strategic thinking, industry expertise, and relationship-building skills needed to forge value-adding deals between technology companies and global pharmaceutical companies is incredibly limited. Coulter Partners not only identified the best candidates but also guided us through the process, ensuring a seamless and efficient outcome."

"I am excited to join Entia and contribute to its mission of improving the lives of cancer patients," said Timothy Broke-Smith. "Entia's innovative technology has the potential to revolutionize cancer care, delivering more proactive at-home monitoring and giving back time to those affected by cancer when they need it the most. I look forward to building the commercialization of Entia’s solutions and delivering meaningful healthcare impact with partners."

----

Timothy Broke-Smith, Senior Vice President of Partnerships

Tim is a senior commercial and operations executive with over 20 years’ experience building international partnerships in life sciences. Driving solutions for pressing healthcare problems through innovation and collaboration across biotech, medtech, digital health and pharma. Previously held CBO, COO and other leadership roles across clinical stage biotech and technology companies. Tim has a wealth of experience across product development, business development and corporate governance in both private and public listed companies, and has completed major partnerships with global pharma addressing significant unmet therapeutic and care needs. Tim is also an active investor and advisor to innovative companies and a proud father.

About Entia

About Coulter Partners